COLL - Collegium Pharmaceutical GAAP EPS of -$0.15 misses by $0.21 revenue of $123.55M beats by $2.33M
- Collegium Pharmaceutical press release ( NASDAQ: COLL ): Q2 GAAP EPS of -$0.15 misses by $0.21 .
- Revenue of $123.55M (+49.0% Y/Y) beats by $2.33M .
- Adjusted EBITDA for the 2022 Quarter was $71.2 million, compared to $40.1 million for the 2021 Quarter
- The Company exited the 2022 Quarter with a cash balance of $122.7 million.
- Raises Full Year Adjusted EBITDA Guidance .
For further details see:
Collegium Pharmaceutical GAAP EPS of -$0.15 misses by $0.21, revenue of $123.55M beats by $2.33M